The Biological Activities and Therapeutic Potentials of Baicalein Extracted from : A Systematic Review
Overview
Affiliations
In Southeast Asia, traditional medicine has a longestablished history and plays an important role in the health care system. Various traditional medicinal plants have been used to treat diseases since ancient times and much of this traditional knowledge remains preserved today. (beko plant) is one of the medicinal herb plants that is widely distributed throughout Asia. It is a versatile plant and almost every part of the plant is reported to possess a wide range of pharmacological activities. Many of the important bioactivities of this medicinal plant is related to the most abundant bioactive constituent found in this plant-the baicalein. Nonetheless, there is still no systematic review to report and vindicate the biological activities and therapeutic potential of baicalein extracted from to treat human diseases. In this review, we aimed to systematically present in vivo and in vitro studies searched from PubMed, ScienceDirect, Scopus and Google Scholar database up to 31 March 2020 based on keywords "" and "baicalein". After an initial screening of titles and abstracts, followed by a full-text analysis and validation, 20 articles that fulfilled all the inclusion and exclusion criteria were included in this systematic review. The searched data comprehensively reported the biological activities and therapeutic potential of baicalein originating from the plant for anti-cancer, antibacterial, anti-hyperglycemia, neurogenesis, cardioprotective, anti-adipogenesis, anti-inflammatory and wound healing effects. Nonetheless, we noticed that there was a scarcity of evidence on the efficacy of this natural active compound in human clinical studies. In conclusion, this systematic review article provides new insight into and its active constituent baicalein as a prospective complementary therapy from the perspective of modern and scientific aspect. We indicate the potential of this natural product to be developed into more conscientious and judicious evidencebased medicine in the future. However, we also recommend more clinical research to confirm the efficacy and safety of baicalein as therapeutic medicine for patients.
Han J, Sun W, Yao Y, Li S, Yue Z, Fang W AAPS PharmSciTech. 2025; 26(3):78.
PMID: 40045016 DOI: 10.1208/s12249-025-03077-9.
Zhang C, Chen L, Xiu Y, Zhang H, Zhang Y, Ying W Front Oncol. 2025; 14:1518567.
PMID: 39902130 PMC: 11788179. DOI: 10.3389/fonc.2024.1518567.
Synergistic combination of baicalein and rifampicin against biofilms.
Muniyasamy R, Manjubala I Front Microbiol. 2024; 15:1458267.
PMID: 39165570 PMC: 11333347. DOI: 10.3389/fmicb.2024.1458267.
Mim J, Sultana M, Dhar P, Hasan M, Dutta S RSC Adv. 2024; 14(35):25409-25424.
PMID: 39139232 PMC: 11320963. DOI: 10.1039/d4ra04132a.
Sreedharan S, Pande A, Pande A, Majeed M, Cisneros-Zevallos L Nutrients. 2024; 16(12).
PMID: 38931243 PMC: 11206423. DOI: 10.3390/nu16121887.